ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

ClinicalTrials.gov ID: NCT03424018

Public ClinicalTrials.gov record NCT03424018. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With Achondroplasia

Study identification

NCT ID
NCT03424018
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
BioMarin Pharmaceutical
Industry
Enrollment
119 participants

Conditions and interventions

Conditions

Interventions

  • BMN 111 Drug

Drug

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 11, 2017
Primary completion
May 31, 2031
Completion
May 31, 2031
Last update posted
Mar 12, 2026

2017 – 2031

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Children's Hospital & Research Center Oakland Oakland California 94609
Harbor - UCLA Medical Center Torrance California 90509
Alfred I. duPont Hospital for Children Wilmington Delaware 19803
Emory University Atlanta Georgia 30322
Ann and Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611
Johns Hopkins University Baltimore Maryland 21287
University of Missouri Columbia Missouri 65201
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Baylor College of Medicine Houston Texas 77030
Seattle Children's Hospital Seattle Washington 98105
Medical College of Wisconsin, Children's Hospital Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03424018, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03424018 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →